Audio Archive
 | July, 2010 (mp3, 10:07 mins, 9.26Mb) |
Roy Herbst discusses the Zodiac trial, a phase 3 study assessing the efficacy of vandetanib for treating advanced non-small-cell lung cancer.
| June, 2010 (mp3, 11:28 mins, 10.4Mb) |
Emma Grainger discusses erlotinib as maintenance treatment for lung cancer, and IGF1 and risk of breast cancer.
| May, 2010 (mp3, 12:12 mins, 11.1Mb) |
The role of zoledronic acid with chemotherapy for early breast cancer and other issue highlights are discussed.
| April, 2010 (mp3, 7:02 mins, 6.44Mb) |
April issue highlights, including a genome-wide association study of lung cancer for never smokers.
| March, 2010 (mp3, 4:55 mins, 4.5Mb) |
March issue highlights, including hypofractionated radiotherapy for early breast cancer.
| February, 2010 (mp3, 7:27 mins, 6.82Mb) |
Discussion of a novel targeted therapy for sarcoma.
| January, 2010 (mp3, 16:18 mins, 14.9Mb) |
Emma Grainger with issue highlights and Kathy Albain discussing chemotherapy and tamoxifen for post-menopausal women with breast cancer.
